Bouchard P

No ORCID on file · 11 papers in corpus · active 1987-2018

Study types

  • review 6
  • other 3
  • article 2

Condition tags

  • endometriosis 10
  • infertility 1
review 2018
Climacteric : the journal of the International Menopause Society ·doi:10.1080/13697137.2017.1386650

Selective progesterone receptor modulators (SPRMs) are steroid progesterone receptor ligands able to induce agonistic or antagonistic activities. Mifepristone, the class leader, was primarily used for pregnancy termination from the 1980s. E…

review 2012
Molecular and cellular endocrinology ·doi:10.1016/j.mce.2012.02.021

Selective progesterone receptor modulators (SPRMs) have been developed since the late 70s when mifepristone was first described. They act through nuclear progesterone receptors and can have agonist or mixed agonist antagonist actions depend…

other 2011
Human reproduction update ·doi:10.1093/humupd/dmr033

BACKGROUND: The Fifth Evian Annual Reproduction (EVAR) Workshop Meeting discussed knowledge regarding contemporary genetics in female reproduction. METHODS: Specialist reproductive medicine clinicians and geneticists delivered presentation…

article 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.08.021

ObjectiveTo discuss the mechanism of action of selective progesterone receptor modulators (SPRMs) and summarize the preclinical and clinical efficacy and safety data supporting the potential use of these compounds for gynecologic indication…

review 2008
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625180802267060

Currently developed progesterone receptor modulators (PRMs) are steroid-derived compounds with mild or potent antiprogestin activity. PRMs may exert a contraceptive activity by different mechanisms such as blockade of ovulation and endometr…

review 2008
Women's health (London, England) ·doi:10.2217/17455057.4.3.269

Progesterone-receptor modulators (PRMs) are progesterone-receptor ligands that can exert agonistic, antagonistic or mixed agonist-antagonist effects depending on the cellular context. The mechanisms of action of these compounds are still in…

other 2008
Bulletin de l'Academie nationale de medecine ·doi:10.1016/s0001-4079(19)32715-3

Progesterone antagonists belong to the family of selective progesterone receptor modulators. SPRMs already have several applications in women's health. Their main value lies in their effect on endometrium. For example, they can be used to r…

other 2005
Annales d'urologie ·doi:10.1016/s0003-4401(05)80009-9

Antagonists act by competitive inhibition of pituitary GnRH receptors for which they have a high affinity with a dose-dependent activity. The inhibition concerns LH but also FSH by inhibiting their secretion for 24 hours. At this time, only…

review 2005
Human reproduction update ·doi:10.1093/humupd/dmi002

Since the discovery of the antiprogestin mifepristone, hundreds of similar compounds have been synthesized, which can be grouped in a large family of progesterone receptor ligands. This family includes pure agonists such as progesterone its…

review 2000
Human reproduction update ·doi:10.1093/humupd/6.4.322

In those clinical situations in which an immediate and profound suppression of gonadotrophins is desired, LHRH agonists have the disadvantage of producing an initial stimulatory effect on hormone secretion. Therefore, the use of GnRH antago…

article 1987
Contributions to gynecology and obstetrics ·doi:10.1159/000414896